Company Filing History:
1 out of 485 
1 out of 3,688 
Years Active: 2011
Title: Zhi-Liang Wei: Innovator in Nicotinic Acetylcholine Receptor Research
Introduction
Zhi-Liang Wei is a notable inventor based in Chicago, IL, who has made significant contributions to the field of pharmacology. His work primarily focuses on the development of ligands for nicotinic acetylcholine receptors, which play a crucial role in various neurological conditions.
Latest Patents
Wei holds a patent titled "Ligands for nicotinic acetylcholine receptors, and methods of making and using them." This invention encompasses heterocyclic compounds that act as ligands for nicotinic acetylcholine receptors. The patent outlines the use of these compounds for modulating mammalian nicotinic acetylcholine receptors and their potential applications in treating a range of disorders, including Alzheimer's disease, Parkinson's disease, and various psychiatric conditions.
Career Highlights
Throughout his career, Zhi-Liang Wei has been associated with prestigious institutions such as Georgetown University and The Johns Hopkins University. His research has contributed to a deeper understanding of the therapeutic potential of nicotinic acetylcholine receptor ligands.
Collaborations
Wei has collaborated with esteemed colleagues, including Alan P. Kozikowski and John L. Musachio, enhancing the impact of his research through shared expertise and innovative ideas.
Conclusion
Zhi-Liang Wei's work in the development of ligands for nicotinic acetylcholine receptors represents a significant advancement in the field of neuroscience. His contributions have the potential to improve treatment options for various neurological and psychological disorders.